Aplastic Anemia: Clinical Trials

25 trials for Aplastic Anemia, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

12 completed, 6 unknown, 3 terminated, 2 recruiting. 25 Phase 1, 16 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	25	Completed 12, Unknown 6, Terminated 3, Recruiting 2, Active not recruiting 1, Not yet recruiting 1
Phase 2	16	Completed 7, Unknown 4, Recruiting 2, Active not recruiting 1, Not yet recruiting 1, Terminated 1

Follow Aplastic Anemia: new trials by email Literature Review of Aplastic Anemia trials Research Report on Aplastic Anemia

Trials (filtered) newest first · largest first

All 25 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Phase I/II Study of Anti-CD38 Monoclonal Antibody in Refractory Severe Aplastic Anemia Isatuximab - Aplastic Anemia	Phase 1 / Phase 2	Recruiting	Institute of Hematology & Blood Diseases Hospital, China	32	2026-06-30	2026-09-21
The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic Anemia Daratumumab - Aplastic Anemia, Refractory	Phase 1 / Phase 2	Recruiting	Institute of Hematology & Blood Diseases Hospital, China	37	2025-12-17	2026-11-06
Study of CM313(SC) Injection in Subjects With Relapsed/Refractory Aplastic Anemia CM313(SC) injection - Aplastic Anemia	Phase 1 / Phase 2	Not yet recruiting	Keymed Biosciences Co.Ltd	125	2025-03-01	2025-02-18
Efficacy of Daratumumab to Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia Daratumumab - Aplastic Anemia, Platelet Transfusion Refractoriness	Phase 1	Completed	Institute of Hematology & Blood Diseases Hospital, China	10	2023-04-17	2025-01-03
Autologous Tregs for Aplastic Anaemia Expanded autologous T regulatory cells - Aplastic Anemia	Phase 1	Unknown	King's College Hospital NHS Trust	12	2022-07-14	2023-10-05
Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization Best Practice, Ibrutinib - Aplastic Anemia, Hematopoietic and Lymphoid Cell Neoplasm	Phase 1	Completed	Jennifer Woyach	10	2020-10-23	2023-12-26
Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant Anti-Thymocyte Globulin, Cyclophosphamide, Cytokine-treated Veto Cells - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia	Phase 1 / Phase 2	Active not recruiting	M.D. Anderson Cancer Center	16	2019-08-08	2026-06-11
Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies Cyclophosphamide, Filgrastim, Fludarabine Phosphate - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia	Phase 1	Completed	M.D. Anderson Cancer Center	11	2017-01-18	2023-02-16
Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Aplastic Anemia mesenchymal stem cells - Aplastic Anemia	Phase 1	Unknown	Hebei Medical University	10	2017-01-01	2017-04-07
Nandrolone Decanoate in the Treatment of Telomeropathies Nandrolone Decanoate - Aplastic Anemia, Bone Marrow Failure Syndromes	Phase 1 / Phase 2	Completed	University of Sao Paulo	20	2014-02-01	2023-08-31
Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination allogeneic donor derived B-lymphocytes - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia	Phase 1 / Phase 2	Unknown	University of Erlangen-Nürnberg Medical School	15	2013-11-01	2014-03-26
Danazol for Genetic Bone Marrow and Lung Disorders Danazol - Aplastic Anemia	Phase 1 / Phase 2	Completed	National Heart, Lung, and Blood Institute (NHLBI)	27	2011-07-19	2018-08-15
Alefacept in Patients With Relapsed/Refractory Aplastic Anemia Alefacept - Aplastic Anemia	Phase 1	Terminated	The Cleveland Clinic	4	2011-05-01	2018-01-26
Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia Intravenous bone marrow mesenchymal stem cells infusion - Aplastic Anemia	Phase 1 / Phase 2	Completed	University of Sao Paulo	9	2011-02-01	2014-02-04
Mesenchymal Stem Cells Transplantation to Patients With Relapsed/Refractory Aplastic Anemia. bone marrow derived mesenchymal stem cells - Aplastic Anemia	Phase 1 / Phase 2	Unknown	Guangzhou General Hospital of Guangzhou Military Command	50	2011-02-01	2011-03-01
Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia Cyclophosphamide, Cyclosporine - Aplastic Anemia, Neutropenia	Phase 1 / Phase 2	Completed	National Heart, Lung, and Blood Institute (NHLBI)	22	2010-08-01	2017-05-22
A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia Cyclophosphamide, Fludarabine - Aplastic Anemia, Neutropenia	Phase 1 / Phase 2	Completed	National Heart, Lung, and Blood Institute (NHLBI)	1	2010-08-01	2021-07-02
Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia anti-thymocyte globulin, filgrastim, Fludarabine - Aplastic Anemia	Phase 1 / Phase 2	Completed	Asan Medical Center	12	2009-07-01	2013-01-03
Study of Fludarabine + Cyclophosphamide + TBI Conditioning Regimen for Double Units Cord Blood Transplantation(CBT)in Severe Aplastic Anemia(SAA) Cyclophosphosphamide, TBI - Aplastic Anemia	Phase 1 / Phase 2	Unknown	The Korean Society of Pediatric Hematology Oncology	5	2008-11-01	2012-03-26
Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones Lo-Ovral Oral Contraceptive Pills, Placebo - sugar pill - Aplastic Anemia, Menorrhagia	Phase 1 / Phase 2	Terminated	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	1	2007-11-01	2013-07-19

Aplastic Anemia: Clinical Trials

25 trials for Aplastic Anemia, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

By phase and status

Trials (filtered) newest first · largest first

Narrower conditions

Broader conditions

Interventions

Sponsors

Countries

Top investigators

Results publications